Intuitive Surgical, Inc. (ISRG) got here out with quarterly earnings of $3.92 per share, beating the Zacks Consensus Estimate of $3.16 per share. This compares to earnings of $1.11 per share a yr in the past. These figures are adjusted for non-recurring gadgets.
This quarterly report represents an earnings shock of 24.05%. 1 / 4 in the past, it was anticipated that this firm would put up earnings of $2.61 per share when it really produced earnings of $3.52, delivering a shock of 34.87%.
Over the past 4 quarters, the corporate has surpassed consensus EPS estimates 4 occasions.
Intuitive Surgical, Inc.Which belongs to the Zacks Medical – Devices trade, posted revenues of $1.46 billion for the quarter ended June 2021, surpassing the Zacks Consensus Estimate by 13.95%. This compares to year-ago revenues of $852.1 million. The corporate has topped consensus income estimates 4 occasions over the past 4 quarters.
The sustainability of the inventory’s rapid value motion based mostly on the recently-released numbers and future earnings expectations will principally rely on administration’s commentary on the earnings name.
Intuitive Surgical, Inc. Shares have added about 14% for the reason that starting of the yr versus the S&P 500’s acquire of 13.4%.
What’s Subsequent for Intuitive Surgical, Inc.
Whereas Intuitive Surgical, Inc. Has outperformed the market up to now this yr, the query that involves buyers’ minds is: what’s subsequent for the inventory?
There aren’t any simple solutions to this key query, however one dependable measure that may assist buyers deal with that is the corporate’s earnings outlook. Not solely does this embody present consensus earnings expectations for the approaching quarter(s), but in addition how these expectations have modified currently.
Empirical analysis reveals a powerful correlation between near-term inventory actions and developments in earnings estimate revisions. Traders can observe such revisions by themselves or depend on a tried-and-tested score software just like the Zacks Rank, which has a powerful observe document of harnessing the ability of earnings estimate revisions.
Forward of this earnings launch, the estimate revisions pattern for Intuitive Surgical, Inc. Was blended. Whereas the magnitude and path of estimate revisions might change following the corporate’s just-released earnings report, the present standing interprets right into a Zacks Rank #3 (Maintain) for the inventory. So, the shares are anticipated to carry out in step with the market within the close to future. You’ll be able to see the entire record of at the moment’s Zacks #1 Rank (Sturdy Purchase) shares right here.
Will probably be fascinating to see how estimates for the approaching quarters and present fiscal yr change within the days forward. The present consensus EPS estimate is $3.26 on $1.32 billion in revenues for the approaching quarter and $13.58 on $5.37 billion in revenues for the present fiscal yr.
Traders ought to be aware of the truth that the outlook for the trade can have a cloth impression on the efficiency of the inventory as properly. By way of the Zacks Business Rank, Medical – Devices is at the moment within the backside 19% of the 250 plus Zacks industries. Our analysis reveals that the highest 50% of the Zacks-ranked industries outperform the underside 50% by an element of greater than 2 to 1.
Zacks’ Prime Picks to Money in on Synthetic Intelligence
In 2021, this world-changing know-how is projected to generate $327.5 billion in income. Now Shark Tank star and billionaire investor Mark Cuban says AI will create “the world’s first trillionaires.” Zacks’ pressing particular report reveals Three AI picks buyers must learn about at the moment.
See Three Synthetic Intelligence Shares With Excessive Upside Potential>>
Click on to get this free report
Intuitive Surgical, Inc. (ISRG): Free Inventory Evaluation Report
To learn this text on Zacks.com click on right here.
Zacks Funding Analysis
The views and opinions expressed herein are the views and opinions of the creator and don’t essentially replicate these of Nasdaq, Inc.